Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avita Medical Inc (NQ: RCEL )

11.40 +1.10 (+10.68%)
Streaming Delayed Price Updated: 12:35 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical Inc

< Previous 1 2 3 Next >
AVITA Medical to Announce Third Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at 2024 Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
AVITA Medical Expands Portfolio with Unique Dermal Matrix to Advance Wound Care
Exclusive development and distribution agreement with Regenity Biosciences provides AVITA Medical with the commercialization rights to a unique collagen-based dermal matrix following 510(k) clearance 
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Second Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Donna Shiroma retires after distinguished service as General Counsel 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Achieves Milestone with First Case Using RECELL GO
Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defects 
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL GO
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports First Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce First Quarter 2024 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Updates Expected First Quarter 2024 Revenue
From AVITA Medical
Via GlobeNewswire
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
AVITA Medical Updates Full Year 2023 Guidance
From AVITA Medical
Via GlobeNewswire
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
From AVITA Medical
Via GlobeNewswire
AVITA Medical to Announce Third Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.